Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committees’ proposal for the Annual General Meeting in Attendo 2020

Description of the nomination committee’s work for the Annual General Meeting The Annual General Meeting 2019 elected the following members of the Nomination Committee: Tomas Billing (representing Nordstjernan), Anssi Soila (representing Pertti Karjalainen), Adam Gerge (representing Didner & Gerge Fonder) and Marianne Nilsson (representing Swedbank Robur Fonder), with Tomas Billing as Chair. The Chair of the Board, Ulf Lundahl, is co-opted in the Nomination Committee, with no voting right. No fees are paid to members of the Nomination Committee. The Nomination Committee has, in

Arcus ASA: Vectura and Cuveco to investigate a merger

Vectura and Cuveco have agreed to investigate a merger of the two companies. In an industry with strong competition and low margins, the two players plan to establish a joint company that will develop even better services to their customers. By merging the two companies, one will also achieve a size that makes it easier to invest for the future in automation, digitalisation and sustainable solutions. Vectura and Cuveco complement each other well. A merger will use the best systems and routines from the two companies, ensuring that a combined company becomes stronger. In the first

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders Herantis Pharma PlcCompany release 11 March 2020 at 9:00 AM Eastern European Time NOTICE TO CONVENE herantis pharma PLC’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Shareholders of Herantis Pharma Plc are invited to attend the Annual General Meeting of the Company on Wednesday, 8 April 2020, commencing at 13.00 pm Eastern European Time at Taitotalon Kongressikeskus, at the address Valimotie 8, Helsinki, Finland. There are a limited number of parking spaces in the area. The reception of participants and the

Semcon strengthens its position within digital training through acquisition

Semcon has today made the acquisition of Stockholm-based company Xtractor, which will become part of business area Product Information. The acquisition means that Semcon is strengthening its position within digital product information through an enhanced expertise in the production of interactive web and mobile training as well as the implementation of Learning Management Systems (LMS).Semcon currently has a world-leading offering within digital product information and has long experience of web-based training solutions in many different industries. The acquisition is expected to have a

Essity publishes its Annual and Sustainability Report for 2019

Hygiene and health company Essity has today published its Annual and Sustainability Report for 2019 on www.essity.com “2019 was a year of strong growth and improved profitability. Through price increases, improved product mix, higher volumes and cost savings, we have more than offset the significant headwinds over the past two years from higher raw material costs. Successful innovations and investments in sales and marketing have strengthened market positions and brands. As part of ongoing efforts to contribute to a sustainable and circular society, we

Elisa's 2019 Annual Report, Financial Statements and Corporate Responsibility Report

ELISA STOCK EXCHANGE RELEASE 11 MARCH 2020 AT 9:00 AMElisa has released an Annual Report website, which contains the 2019 Financial Statements with notes, the verified Corporate Responsibility Report prepared according to the GRI standards that is also a statement of Elisa’s non-financial information, and the Corporate Governance Statement released on 29 January 2020. PDF files are enclosed to this stock exchange release. The Annual Report is available at www.elisa.com/annualreport in Finnish and English. It can also be accessed on the company website at www.elisa.com/investors. ELISA

Northmill invests in customer experience

- A vital step to meet all customers on their termsStockholm 11 March 2020: The Swedish tech bank Northmill has invested in a new cloud-based platform from leading CRM company Zendesk, Inc. That today is being used by companies such as Airbnb and Uber. The purpose of the investment is to give the employees the best possible tools to meet all the customers on their terms. At the same time, the tech bank aims to strengthen the connection between the customers’ feedback and what type of products and features are being developed. Simon Nilsson, Chief Customer Officer at Northmill commented:

Componenta appoints new President and CEO

Componenta Corporation Stock Exchange Release on 11 March 2020 at 9.00 Componenta Corporation’s Board of Directors has appointed M.Sc. (Eng.) Sami Sivuranta, 45, as the new President and CEO of Componenta. Since September 2019, Sivuranta has held the position of Director Business Development at Componenta, and during years 2004 – 2016 he has worked in various managerial positions at Componenta. Sivuranta has also served as Director Business Development at Parma Ltd. during  2016 – 2017 and as Executive Vice President Operations at HKScan Corporation during 2017 – 2019. The appointment

The election committee’s proposal of board of directors for the Annual General Meeting 2020

Railcare Group AB (publ)’s election committee proposes that the Annual General Meeting re-elect the current members of the board of directors Catharina Elmsäter-Svärd, who is also proposed to be re-elected as chairman of the board, Ulf Marklund, Anna Weiner Jiffer, Adam Ådin, Anders Westermark and Björn Östlund. In addition, the election committee propose that the Annual General Meeting resolves on a remuneration to non-employed board members elected by the general meeting and non-employed members of the board of directors’ various committees shall be, SEK 200 000 to the chairman of the

Systemair AB Interim Report Q3 2019/20

Press Release, March 11, 2020 Third quarter November 2019 – January 2020 · Net sales increased by 6.4 percent to SEK 2,147 million (2,018). · Organic growth was 1.8 percent (6.2). · Operating profit (EBIT) totalled SEK 113 million (80). · The operating margin was 5.2 percent (4.0). · Profit after tax amounted to SEK 64 million (45). · Earnings per share totalled SEK 1.20 (0.85). · Cash flow from operating activities amounted to SEK 288 million (189). Roland Kasper, President and CEO, comments: “During the third quarter, growth was recorded at 6.4 percent, of

Clifford Chance to present final report on Swedbank on 23 March, 2020

The international law firm Clifford Chance has, on behalf of the Board of Swedbank, analysed the bank’s work on anti-money laundering.The investigation includes customers, transactions and activities from 2007 through March 2019 and how the bank has handled internal and external information disclosures. Clifford Chance has also assessed Swedbank's historical response to previously identified deficiencies.  On 23 March, at 10:00 am CET, Clifford Chance will present its report at a press conference. Following the press conference, Chairman of the Board Göran Persson, and President and

Axactor Annual Report 2019

Oslo, March 11th 2020 Axactor has published its Annual Report for 1 January 2019 to 31 December 2019. The Financial Review, including the Report by the Board of Directors, Financial Statements and the Corporate Governance Statement, is also available on the company’s website www.axactor.com.  The Corporate Governance Statement has been prepared in accordance with the Norwegian Corporate Governance Code (NUES). Axactor’s Sustainability Report 2019 is integrated into the Annual Report.    For additional information, please contact:  Endre Rangnes, CEO, AxactorMobile phone:

Nixu Gamifies Cybersecurity Awareness – Serious Training Can Be Entertaining

Nixu Corporation, Press release, March 11, 2020, at 8:00 AM EETEuropean cybersecurity company Nixu is concerned about the growing level of phishing that can harm people from all walks of life and across all levels of society. Training has a great preventive effect as it helps people to effectively improve their social engineering awareness and identify and prevent phishing. As technologies and cyber defense protection continue to improve, criminals tend to exploit the human weaknesses of employees to gain easier access to an organization's information and systems. With a clever social

Clas Ohlsons nine-month report 2019/20

Improved profitabilityThird quarter – 1 November 2019 to 31 January 2020 · Sales in the Nordics increased by 2% to 2,883 MSEK (2,823), organic growth up 2% and total sales as well as organic growth were unchanged at 2,905 MSEK (2,915) · Online sales increased 19% to 177 MSEK (148) · Operating profit, including non-recurring costs and costs linked to the CO100+ action programme, totalled 378 MSEK (105). Excluding the effect of IFRS 16, operating profit amounted to 355 MSEK · Underlying operating profit amounted to 368 MSEK (363) (excl IFRS 16) · The operating margin was 13.0%

Targovax ASA: Annual Report 2019

On 10 March 2020, the Board of Directors of Targovax ASA approved the Company's financial statements for 2019, which will be processed at the Company's annual general meeting on 29 April 2020. The Company's annual accounts for the financial year 2019, including the financial statements and annual report for the financial year 2019, are together with the auditor's report attached to this notice. The documents are also available at the Company's website, www.targovax.com . Targovax Annual Report 2019 

Targovax ASA: Fourth quarter 2019 results

Oslo, Norway, 11 March 2020 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its fourth quarter 2019 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET (details below). HIGHLIGHTS FOR THE FOURTH QUARTER 2019 · In October, Targovax was selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting. The presentation was given by Dr. Alexander Shoushtari, Principal Investigator of ONCOS-102 trial in

Smart control of power plants to support the growth of renewable energy

The fluctuating supply of wind and solar energy forces traditional power plants to be more flexible. The two-year SmartFlex project develops smart monitoring and control tools that can be used to control power plants in rapidly changing situations. The aim is to extend the lifespan of the plants as well as to maintain high efficiency and low emissions in a reliable way.Conventional combined heat and power (CHP) production balances the fluctuation that wind and solar power bring to the energy market. CHP plants also provide an opportunity to combust biomass residues as well as waste, thus

BRAbank ASA: BRA-ME - Completion of private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Bergen, 10 March 2020 Reference is made to the stock exchange announcement published on 5 March 2020 regarding launch of a private placement in BRAbank ASA ("BRAbank" or the "Company"). BRAbank announces that its Board of Directors has resolved to

Biovica provides updates on FDA application

Uppsala, Sweden, March 10, 2020. Biovica, active in cancer diagnostics, today announced that the company intends to submit an FDA application for market approval of DiviTum in the third quarter of 2020 and not as previously announced in mid-2020.“We are pleased with our results in the analytical validation, which is part of our FDA application and so far meet the criteria we have set. However, a component supplier has had delivery delays which means that we now anticipate being able to submit the FDA application a little later than previously expected,” said Anders Rylander, CEO of Biovica.

Norwegian Minister of Climate and Environment opened upgraded furnace at Elkem Bremanger

10 MARCH 2020: The Norwegian Minister of Climate and Environment, Sveinung Rotevatn, today opened the upgraded silicon furnace at Elkem Bremanger in Norway. The upgrade increases the plant’s cost efficiency and reduces NOx emissions with up to 50% – similar to removing 100.000 diesel cars from the road.Around NOK 250 million has been invested in the upgrade. The Norwegian NOx fund has supported the project with NOK 90 million. In addition to improving cost efficiency and cut NOx emissions, the project has additional benefits, when it comes to safety standards and work environment. “Elkem

Neste to acquire Mahoney Environmental to strengthen its growth strategy and position in renewable raw material sourcing

Neste Corporation, Press Release, 10 March 2020 at 9.55 p.m. (EET)  Neste, the world's leading producer of renewable diesel and sustainable aviation fuel produced from waste and residue raw materials, has agreed to acquire 100% of Mahoney Environmental (Mahoney), a collector and recycler of used cooking oil in the United States, and its affiliated entities. The transaction is subject to the fulfillment of customary closing conditions and regulatory approval. “This is another important step for Neste in the execution of our growth strategy. With this acquisition we will gain

Bong makes bond repurchase

Bong AB (publ) has made a repurchase of its own senior secured notes on the market. The repurchase was made to the nominal amount of SEK 10 million. The repurchase is related to the company’s own bond loan with an outstanding nominal amount before the repurchase of 210 MSEK which Bong issued in October 2018 with a 3 year tenure at the interest rate of Stibor (3m) +10 %. The senior secured notes are listed on Nasdaq Stockholm’s Corporate Bonds List with ISIN: SE0011281419. Bong is one of the leading providers of envelope products in Europe that also offers solutions for distribution

Cereno Scientific Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

Cereno Scientific today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s lead compound CS1, for the treatment of Pulmonary Arterial Hypertension (PAH). PAH is a form of high blood pressure in the lungs where the increased pressure is primarily caused by changes in the lung vessels.CS1 is a reformulation of valproic acid (VPA), an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties. These characteristics are a good match

There are no items matching the current filter
There are no more items matching the current filter
Back to top